Related Experiment Video
Updated: Jul 15, 2026
09:36
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Catecholaminergic polymorphic ventricular tachycardia
Nian Liu1, Barbara Colombi, Emilia V Raytcheva-Buono
1Molecular Cardiology, Fondazione Salvatore Maugeri, Pavia, Italy.
Herz
|May 15, 2007
Summary
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a dangerous inherited heart condition. Early diagnosis via genetic screening and exercise tests, along with beta-blockers, improves management but some patients still need defibrillators.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a life-threatening inherited arrhythmia.
- It presents as adrenergically mediated polymorphic ventricular tachycardia, often triggered by stress.
- Mutations in RYR2 and CASQ2 genes cause dominant and recessive CPVT, respectively.
Purpose of the Study:
- To summarize the key aspects of CPVT, including its genetic basis, clinical presentation, diagnosis, and management.
- To highlight the high mortality rate in untreated CPVT patients.
- To emphasize the importance of early diagnosis and treatment strategies.
Main Methods:
- Review of clinical presentations, including exercise- or emotion-induced syncope.
- Diagnostic approaches such as exercise stress testing, Holter monitoring, and genetic screening.
- Evaluation of treatment efficacy, focusing on beta-adrenergic blockers and implantable cardioverter-defibrillators.
Main Results:
- CPVT is characterized by stress-related, bidirectional ventricular tachycardia without structural heart disease or prolonged QT.
- Untreated individuals face a 30-50% mortality rate by age 40.
- While beta-blockers are effective, approximately 30% of patients require an implantable cardioverter-defibrillator.
Conclusions:
- Early diagnosis of CPVT through clinical evaluation and genetic testing is crucial.
- Beta-adrenergic blockers are the cornerstone of pharmacological management.
- Despite treatment, a significant subset of CPVT patients necessitates advanced interventions like defibrillators due to persistent arrhythmias.
Related Concept Videos
01:29Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:28Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.